Table 2.
Relationship between expression of RECK, MMP-2, MMP-9 and clinicopathologic features
Variables | Category | RECK | P | MMP-2 | P | MMP-9 | P | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|||||||||
low | high | low | high | low | high | ||||||
Gender | male | 64 | 30 | 34 | 0.94 | 14 | 50 | 0.247 | 12 | 52 | 0.012 |
female | 44 | 22 | 22 | 14 | 30 | 18 | 26 | ||||
Age | <60 | 44 | 20 | 24 | 0.642 | 9 | 35 | 0.164 | 16 | 28 | 0.099 |
≥60 | 64 | 32 | 32 | 19 | 45 | 14 | 50 | ||||
Differentiation | well | 62 | 18 | 44 | 0 | 24 | 38 | 0.001 | 28 | 34 | 0 |
mod/poor | 46 | 34 | 12 | 4 | 42 | 2 | 44 | ||||
Lymph node metastasis | yes | 50 | 38 | 12 | 0.019 | 6 | 44 | 0.002 | 7 | 43 | 0.003 |
no | 58 | 14 | 44 | 22 | 36 | 23 | 35 | ||||
T stage | T1, T2 | 62 | 18 | 44 | 0 | 26 | 36 | 0 | 28 | 34 | 0 |
T3, T4 | 23 | 34 | 12 | 2 | 44 | 2 | 44 |
P<0.05.